Enrollment in 4D-150 Phase 3 wet AMD clinical trials exceeding expectations; 4FRONT-1 trial remains on track to complete enrollment in Q1 2026, ...
Enrollment in 4D-150 Phase 3 wet AMD clinical trials exceeding expectations; 4FRONT-1 trial remains on track to complete enrollment in Q1 2026, with 381 patients randomized or approved to randomize as ...
Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.
CC students and campus officials: Title IX rules do not sufficiently protect alleged assault victims
Title IX officer at Colorado Colleges said his office is "handcuffed by the requirements" of federal regulations when ...
Apple® today unveiled Apple Creator Studio, a groundbreaking collection of powerful creative apps designed to put studio-grade power into the hands of everyone, building on the essential role Mac®, ...
Data management is the process businesses use to gather, store, access and secure data from various platforms. Managing this information properly helps organizations utilize data analytics to gain ...
A looming copper supply gap is poised to widen as electricity demand accelerates and new vectors—such as the race for ...
Vector Security has provided intelligent security solutions for more than 50 years. Headquartered in Pittsburgh, the company offers a full suite of electronic security services for residential, ...
When Grief Becomes Advocacy: How Air Crash Family Groups Reshape Safety, Accountability, and the Law
Families of air disaster victims have played a key role in driving safety reforms by exposing failures, demanding ...
The gene therapy market is surging toward $36.55 billion by 2032, powered by rising demand for curative treatments that target genetic diseases at their source([1]) . The FDA approved three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results